Kolexia
Renaudineau Yves
Pharmacien
Hôpital Purpan
Toulouse, France
178 Activités
961 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Syndrome de Gougerot-Sjögren Lupus érythémateux disséminé Maladies auto-immunes Polyarthrite rhumatoïde Leucémie chronique lymphocytaire à cellules B Arthrite Leucémie lymphoïde Leucémies Inflammation

Industries

Abbvie
1 collaboration(s)
Dernière en 2020
Amgen
1 collaboration(s)
Dernière en 2020
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Impact of imlifidase treatment on immunoglobulins in an HLA-hypersensitized lupus nephritis patient with anti-SSA/SSB antibodies after kidney transplantation: A case report.
Journal of translational autoimmunity   01 décembre 2023
Orai1 Ca channel modulators as therapeutic tools for treating cancer: Emerging evidence!
Biochemical pharmacology   29 novembre 2023
Predictive risk factors before the onset of familial rheumatoid arthritis: the Tatarstan cohort study.
Frontiers in medicine   09 octobre 2023
Low performance of interferon gamma release assay Quantiferon-TB gold coupled or not with Pst1/3/lipoglycan humoral detection to predict Mycobacterium tuberculosis complex disease in a low-burden area.
Tuberculosis (Edinburgh, Scotland)   05 octobre 2023
Lupus Nephritis Risk Factors and Biomarkers: An Update.
International journal of molecular sciences   25 septembre 2023
Infectious risk when prescribing rituximab in patients with hypogammaglobulinemia acquired in the setting of autoimmune diseases.
International immunopharmacology   03 juin 2023
Glucocorticoids selectively affect the memory T cell response to SARS-Cov2 spike in vaccinated and post-infected patients with systemic lupus erythematosus.
Journal of translational autoimmunity   06 avril 2023
Immunological and translational key challenges in systemic lupus erythematosus: A symposium update.
Journal of translational autoimmunity   31 mars 2023
Cerebrospinal fluid YKL-40 level evolution is associated with autoimmune encephalitis remission.
Clinical & translational immunology   15 mars 2023
JAK inhibition for CD3 CD4 lymphocytic-variant hypereosinophilic syndrome.
Clinical immunology (Orlando, Fla.)   02 mars 2023